4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001641172-25-005073
Options or other derivatives
- CEO acquired 0 shares (option exercise)
- CEO acquired 7,551 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pershing Edward CEO | 2025-04-11 | Option exercise · 8% Unsecured Convertible Promissory Note | −0 | D: show line 1 in the form | ||||||
| Pershing Edward CEO | 2025-04-11 | Option exercise · Series D-1 Convertible Preferred Stock | +7,551 | 2,063,538 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…